By vgreene, 16 July, 2024 tirzepatide Zepbound other semaglutide containing drugs that are not FDA approved for obesity mgmt Mounjaro
By rray, 12 July, 2024 Chronic indwelling cath urethral suprapubic recommended only when OAB therapies are contraindicated ineffective or no longer desired and always in the context of shared decision making EO
By rray, 12 July, 2024 Complications of both urethral cath and SPT nbsp nbsp Common cath assoc UTI bladder calculi cath obstruction bladder spasms pain darr bladder capacity urine leakage nbsp nbsp Long term use assoc w uarr hazard ratio for bladder cancer 4 8 vs matched contro
By rray, 12 July, 2024 Suprapubic tube SPT nbsp nbsp Preferred option due to darr likelihood of urethral damage nbsp nbsp Risks bowel perforation and vascular injury which can be mitigated w routine use of U S guided SPT placement development of granulation tissue bleeding cath
By rray, 12 July, 2024 Urethral cath nbsp nbsp Risks urethral trauma including erosion and in severe cases urethral loss significant urinary incontinence need for reconstructive surgery nbsp nbsp Regular f u needed to detect potential signs of urethral trauma nbsp nbsp Increasi
By rray, 12 July, 2024 In severely affected pts who haven t responded to other tx options may offer bladder augmentation cystoplasty or urinary diversion EO